Showing results (61-70 of 206) with videos related to
Sort By:
Pageof 21
Journal of Substance Use and Addiction Treatment|May 13, 2024
Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changesLindsey R Hammerslag, Jeffery Talbert, Svetla Slavova, et al.Therapeutic Advances in Infectious Disease|July 18, 2022
Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infectionsLaura C Fanucchi, Sean M Murphy, Hilary Surratt, et al.Journal of Addiction Medicine|March 18, 2025
Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation SettingHannah K Knudsen, Amanda Fallin-Bennett, Laura Fanucchi, et al.Journal of Addiction Medicine|April 10, 2024
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased MortalityFeitong Lei, Michelle R Lofwall, Jana McAninch, et al.The Journal of Nervous and Mental Disease|December 17, 2008
Changing profile of abused substances by older persons entering treatmentMichelle R Lofwall, Alyson Schuster, Eric C StrainFrontiers in Public Health|March 1, 2024
The development of a recovery coaching training curriculum to facilitate linkage to and increase retention on medications for opioid use disorderTrevor Moffitt, Amanda Fallin-Bennett, Laura Fanucchi, et al.Journal of Addiction Medicine|April 7, 2025
Dosing to Effect With Weekly and Monthly Subcutaneous and Daily Sublingual Buprenorphine: Post Hoc Analysis of a Phase 3 Clinical TrialMichelle R Lofwall, Edward V Nunes, Sharon L Walsh, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 28, 2023
Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorderGail D'Onofrio, Jeanmarie Perrone, Kathryn F Hawk, et al.Journal of Addiction Medicine|June 23, 2025
Description of Physician Champion Efforts to Expand Buprenorphine Treatment in Primary Care and Explore a Quality Implementation Measure of Success: Buprenorphine as a Percentage of All Opioids PrescribedThaddeus R Salmon, Anna-Maria South, Michelle R LofwallNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 29, 2015
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked CannabisMargaret Haney, Robert J Malcolm, Shanna Babalonis, et al.Pageof 21